rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
45
|
pubmed:dateCreated |
1996-12-30
|
pubmed:abstractText |
We have studied the effects of peptide aldehyde protease inhibitors on the secretion of beta-amyloid peptide 1-40 (Abeta(1-40)) and Abeta(1-42) by HEK 293 and COS-1 cells expressing beta-amyloid precursor protein with the Swedish double mutation. A multiphasic SDS-polyacrylamide gel electrophoresis system was used for the discrimination of Abeta(1-40) and Abeta(1-42). Calpain inhibitor I, carbobenzoxyl-Leu-Leu-leucinal, and calpeptin were found to reduce the amount of Abeta(1-40) released into the medium in a dose-dependent manner. The reduction of Abeta(1-40) after treatment with 50 microM calpain inhibitor I or 5 microM carbobenzoxyl-Leu-Leu-leucinal was accompanied by a slight increase of Abeta(1-42) released into the medium. These observations suggest that the cleavages at residues 40 and 42 are accomplished by different enzyme activities.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid Precursor Protein Secretases,
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/BACE1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Proteinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Leupeptins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/amyloid beta-protein (1-40),
http://linkedlifedata.com/resource/pubmed/chemical/amyloid beta-protein (1-42),
http://linkedlifedata.com/resource/pubmed/chemical/benzyloxycarbonylleucyl-leucyl-leuci...,
http://linkedlifedata.com/resource/pubmed/chemical/calpain inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
28655-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8910499-Amyloid Precursor Protein Secretases,
pubmed-meshheading:8910499-Amyloid beta-Peptides,
pubmed-meshheading:8910499-Animals,
pubmed-meshheading:8910499-Aspartic Acid Endopeptidases,
pubmed-meshheading:8910499-COS Cells,
pubmed-meshheading:8910499-Cysteine Proteinase Inhibitors,
pubmed-meshheading:8910499-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:8910499-Endopeptidases,
pubmed-meshheading:8910499-Glycoproteins,
pubmed-meshheading:8910499-Humans,
pubmed-meshheading:8910499-Leupeptins,
pubmed-meshheading:8910499-Peptide Fragments,
pubmed-meshheading:8910499-Tumor Cells, Cultured
|
pubmed:year |
1996
|
pubmed:articleTitle |
The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities.
|
pubmed:affiliation |
Department of Preclinical Research, Sandoz Pharma Ltd., CH-4002 Basel, Switzerland.
|
pubmed:publicationType |
Journal Article
|